Patent Yard Sign in
European application, no grantEurope

Matrix metalloproteinase inhibitors and uses thereof

EP 1772452 A2 · Applicant: Bristol-Myers Squibb Pharma Company

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 15, 2001 and never granted as a European patent. Had it been granted, its 20-year term would have ended February 15, 2021.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by August 15, 2026.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledFebruary 15, 2001
PublishedApril 11, 2007
GrantedNever granted
Term endedFebruary 15, 2021
Application numberEP 06076915
Classification (CPC)C07D267/00 +2 more

Timeline

Timeline From EPO dates

2002200420062008201020122014201620182020Application filedFeb 15, 2001PublishedApril 11, 2007Term endedFeb 15, 2021

Sources & verification